HomeACUR • OTCMKTS
add
Acura Pharmaceuticals Inc
Previous close
$0.0022
Day range
$0.0023 - $0.0023
Market cap
139.33K USD
Avg Volume
2.14K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | 2021info | Y/Y change |
---|---|---|
Revenue | 1.56M | -56.22% |
Operating expense | 1.25M | -33.32% |
Net income | -879.00K | 27.24% |
Net profit margin | -56.24 | -66.19% |
Earnings per share | — | — |
EBITDA | -1.14M | -3,360.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | 2021info | Y/Y change |
---|---|---|
Cash and short-term investments | 65.00K | -84.26% |
Total assets | 860.00K | -50.46% |
Total liabilities | 682.00K | -91.06% |
Total equity | 178.00K | — |
Shares outstanding | 66.00M | — |
Price to book | ∞ | — |
Return on assets | -58.46% | — |
Return on capital | -200.73% | — |
Cash Flow
Net change in cash
(USD) | 2021info | Y/Y change |
---|---|---|
Net income | -879.00K | 27.24% |
Cash from operations | -742.00K | -3.20% |
Cash from investing | — | — |
Cash from financing | 394.00K | 45.93% |
Net change in cash | -348.00K | 22.49% |
Free cash flow | -1.10M | -238.17% |
About
Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR". Wikipedia
Founded
1935
Headquarters
Website
Employees
9